Bibliography: library/10665-42458

The reference for library/10665-42458 (who-iris) and any references extracted from it. library · All references.

Export these 65 references: BibTeX · CSL-JSON · RIS · Dublin Core XML · Dublin Core / BIBO JSON-LD

✍ + Add reference (standalone node)

Build a standalone folio-reference/v1 node at references/reference.jsonld from fields or pasted BibTeX / CSL-JSON.



· ✍ Create standalone node on GitHub · Download .jsonld · Download .csl.json ·

65 shown

  1. World Health Organization (2001). Herpes simplex virus type 2 : programmatic and research priorities in developing countries : report of a WHO/UNAIDS/LSHTM workshop, London, 14-16 February 2001. World Health Organization.
    10665-42458 · catalogue · link · repository record · ISBN 9291731447 · source: catalogue/records/10665-42458.dc.json · held: library/10665-42458
    export: BibTeX · RIS · CSL-JSON · DC XML
  2. Uganda 74% (f); 57% (m) Wagner et al, 1994 Congo 71% Nahmias et al, 1990 Kenya 68% (f); 35% (m)
    · extracted · source: references/10665-42458.sec-004.1.json
  3. Weiss et al, 2001 Zambia 55% (f); 36% (m)
    · extracted · source: references/10665-42458.sec-004.2.json
  4. Weiss et al, 2001 Hospital workers (rural) 51% Nahmias et al, 1990 Cameroon Adults (urban) 51% (f); 27% (m)
    · extracted · source: references/10665-42458.sec-004.3.json
  5. Weiss et al, 2001 Costa Rica Adult women 43% (f)
    · extracted · source: references/10665-42458.sec-004.4.json
  6. Nahmias et al, 1990 Tanzania 42%(f);19%(m)2 Obasi et al, 1999 1990/91 42% Smith et al, 2001 Zaire 41% Nahmias et al, 1990 33% Nahmias et al, 1990 Benin 30% (f); 12% (m)
    · extracted · source: references/10665-42458.sec-004.5.json
  7. Weiss et al, 2001 Blood donors (urban) 29% Da Rosa-Santos et al, 1996 Army Recruits (rural) 28% (m)
    · extracted · source: references/10665-42458.sec-004.6.json
  8. Nahmias et al, 1990 Senegal Surgical patients (urban) 20% Nahmias et al, 1990 PhilippinesAdults (urban) 1991/93 9% Smith et al, 2001 China Gynaecology clinic (urban) 1984-5 2% (f)
    · extracted · source: references/10665-42458.sec-004.7.json
  9. Nahmias et al, 1990 1 (f) females; (m) males 2 Age-weighted sample: younger age-groups were over-represented HSV2 AS A MARKER FOR SEXUAL BEHAVIOUR As HSV2 is more readily transmitted sexually than HIV, HSV2 serology may be a useful marker for changes in sexual behaviour in HIV intervention studies. However, the persistent nature of the infection implies that seroprevalence may not be a sensitive marker of behaviour change, although it will be more discriminating at the lower prevalences seen in younger age groups [Obasi et al., 1999]. HSV2 seroincidence would be a preferable marker of behaviour change, especially in countries in sub-Saharan Africa where there is high incidence among young people.
    · extracted · source: references/10665-42458.sec-004.8.json
  10. There are currently few data on HSV2 prevalence from many parts of the world, including Asia, South America and many parts of Africa. HSV2 incidence data are also scarce [Kamali et al., 1999; McFarland et al., 1999; Hayes et al., 2001]. Prevalence and incidence data are necessary: i) to estimate population attributable fractions (PAFs) for HIV; ii) as background data to inform future intervention studies, such as HSV2 4. EPIDEMIOLOGY AND NATURAL HISTORY OF HSV2 treatment and vaccine trials; iii) to evaluate the need for changes in syndromic management of GUD due to presence of genital herpes; and iv) to evaluate the need for regular HSV2 seroprevalence surveys.
    · extracted · source: references/10665-42458.sec-004.9.json
  11. Genital herpes can also be due to HSV1 infection, and a study in Scotland found that 40% of genital herpes was due to HSV1 in 1991 [Ross et al., 1993]. Both HSV1 and HSV2 are able to infect and reactivate in the same anatomic area, although the natural history of these infections is markedly different, with HSV2 recurring more frequently than HSV1, so most clinical reactivations are likely to be due to HSV2 [Sucato et al., 1998]. In developing countries, the proportion of genital herpes caused by HSV1 is unknown, although assumed to be low.
    · extracted · source: references/10665-42458.sec-004.10.json
  12. Corey L, Mindel A, Fife KH, Sutherland S, Benedetti J,Adler MW. Risk of recurrence after treatment of first-episode genital herpes with intravenous aciclovir. Sex Trans Dis 1985; 12 (4):215-218.
    · extracted · source: references/10665-42458.sec-024.1.json
  13. Corey L, Langenberg AGM,Ashley R, Sekulovich RE, Izu AE, Douglas JM, Handsfield HH et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection. Two randomized controlled trials. JAMA 1999; 331-340.
    · extracted · source: references/10665-42458.sec-024.2.json
  14. Cowan FM, Johnson AM,Ashley R, Corey L, Mindel A.Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994; 309 (6965): 1325-9.
    · extracted · source: references/10665-42458.sec-024.3.json
  15. Cowan FM.Testing for type-specific antibody to herpes simplex virus - implications for clinical practice. J Antimicrob Chemother 2000; 45 Supplement T3: 9-13.
    · extracted · source: references/10665-42458.sec-024.4.json
  16. Da Rosa-Santos OL, Goncalves da Silva A & Pereira AC. Herpes simplex virus type 2 in Brazil: seroepidemiological survey. Int J Dermat 1996; 35: 794-796.
    · extracted · source: references/10665-42458.sec-024.5.json
  17. European Study Group on Heterosexual Transmission of HIV: Comparison of female to male and male to female transmission of HIV in 563 stable couples. Br Med J 1992, 304: 809-13.
    · extracted · source: references/10665-42458.sec-024.6.json
  18. Fennema JS,Van Ameijden EJ, Coutinho RA,Van den Hoek AA. HIV, sexually transmitted diseases and gynaecologic disorders in women: increased risk for genital herpes and warts among HIV-infected prostitutes in Amsterdam. AIDS 1995; 9 (9): 1071-8.
    · extracted · source: references/10665-42458.sec-024.7.json
  19. Fife KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS. Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with aciclovir.Aciclovir Study Group. J Infect Dis 1994; 169 (6): 1338-41.
    · extracted · source: references/10665-42458.sec-024.8.json
  20. Fleming DT, McQuillan GM, Johnson RE ET al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337 (16):1105-11.
    · extracted · source: references/10665-42458.sec-024.9.json
  21. Frenkel LM, Garratty EM, Shen JP,Wheeler N, Clark O, Bryson YJ. Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med 1993; 118 (6): 414-8.
    · extracted · source: references/10665-42458.sec-024.10.json
  22. Goldberg LH, Kaufman R, Kurtz TO, et al. Long-term suppression of recurrent genital herpes with aciclovir.A 5-year benchmark.Aciclovir Study Group. Arch Dermatol 1993; 129 (5): 582-7.
    · extracted · source: references/10665-42458.sec-024.11.json
  23. Halioua B, Malkin JE. Epidemiology of genital herpes - recent advances. Eur J Dermatol 1999; 9 (3): 177-84.
    · extracted · source: references/10665-42458.sec-024.12.json
  24. Hart GJ, Pool R, Green G, Harrison S, Nyanzi S,Whitworth JA.Women’s attitudes to condoms and female-controlled means of protection aganinst HIV and STDs in south-western Uganda. AIDS Care 1999; 11 (6): 687-98.
    · extracted · source: references/10665-42458.sec-024.13.json
  25. Hayes RJ, Pujades Rodriguez MM, Obasi A, Mosha F, et al. Herpes simplex virus type 2 infection increases HIV incidence in rural Tanzania.Abstract of presentation to the ISSTDR/IUSTI Conference, Berlin, Germany 24-27 June 20001. Int J STD AIDS 12 (supp 2): 62-63. Htun Y, Fehler G,Tshabalala V, Radebe F, Ballard R. Genital ulcer diseases in Africa: epidemiological trends.WHO/UNAIDS/LSHTM Workshop on «HSV2: Programmatic and Research Priorities in Developing Countries», London, 14-16th February 2001.
    · extracted · source: references/10665-42458.sec-024.14.json
  26. Ionnidis JP, Collins AC, Cooper DA et al.Clinical efficacy of high-dose acyclovir in patients with HIV infection: a meta-analysis of randomized individual patient data. J Infect Dis. 1998: 178: 349-359.
    · extracted · source: references/10665-42458.sec-024.15.json
  27. Jennings R, Clegg A.The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in-vitro. J Antimicrob Chemother 1993; 32 (1): 71-82.
    · extracted · source: references/10665-42458.sec-024.16.json
  28. Kamali A, Nunn AJ, Mulder DW,Van Dyck E, Dobbins JG,Whitworth JA. Seroprevalence and incidence of genital ulcer infection in a rural Ugandan population. Sex Transm Inf 1999; 75: 98-102.
    · extracted · source: references/10665-42458.sec-024.17.json
  29. Kilmarx PH, Limpakarnjanarat K, Mastro TD et al. HIV-1 seroconversion in a prospective study of female sex workers in northern Thailand: continued high incidence among brothel-based women. AIDS 1998; 12: 1889-98.
    · extracted · source: references/10665-42458.sec-024.18.json
  30. Kinghorn GR. Epidemiology of genital herpes. J Int Med Res 1994; 22 (Suppl 1): 14A-23A.
    · extracted · source: references/10665-42458.sec-024.19.json
  31. Koelle DM,Wald A. Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother 2000; 45 Suppl T3: 1-8.
    · extracted · source: references/10665-42458.sec-024.20.json
  32. Krone MR,Wald A,Tabet SR, Paradise M, Corey L, Celum CL. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis 2000; 30 (2): 261-7.
    · extracted · source: references/10665-42458.sec-024.21.json
  33. Langenberg A, Benedetti J, Jenkins J,Ashley R,Winter C, Corey L. Development of clinically recognizable genital lesions among women previously identified as having «asymptomatic» herpes simplex virus type 2 infection. Ann Intern Med 1989; 110 (11): 882-7.
    · extracted · source: references/10665-42458.sec-024.22.json
  34. Langenberg AG, Corey L,Ashley RL, Leong WP, Straus SE.A prospective study of new infections with herpes simplex viurs type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341 (19) 1432-8.
    · extracted · source: references/10665-42458.sec-024.23.json
  35. Mbopi Keou FX, Gresenguet G, Mayaud P, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000; 182 (4):1090-6.
    · extracted · source: references/10665-42458.sec-024.24.json
  36. McFarland W, Gwanzura L, Bassett MT, et al. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis 1999; 180 (5): 1459-65.
    · extracted · source: references/10665-42458.sec-024.25.json
  37. Mertz GJ, Benedetti J,Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116 (3): 197-202.
    · extracted · source: references/10665-42458.sec-024.26.json
  38. Mertz GJ. Epidemiology of genital herpes infections. Infect Dis Clin North Am 1993; 7 (4): 825-39.
    · extracted · source: references/10665-42458.sec-024.27.json
  39. Mole L, Ripich S, Margolis D, Holodniy M.The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997; 176 (3): 766-70.
    · extracted · source: references/10665-42458.sec-024.28.json
  40. Nahmias AJ, Lee FK, Backman-Nahmias S. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990; S69: 19-36.
    · extracted · source: references/10665-42458.sec-024.29.json
  41. Nicolosi A, Correa Leite ML, Musicco M,Arici C, Gavazzeni G, Lazzarin A:The Efficiency of Male-to-Female and Female-to-Male Sex Transmission of the Human Immunodeficiency Virus:A study of 730 Stable Couples. Epidemiology 1994, 5(6): 570-5.
    · extracted · source: references/10665-42458.sec-024.30.json
  42. Obasi A, Mosha F, Quigley M, et al.Antibody to herpes simplex virus type 2 as a marker of sexual risk behaviour in rural Tanzania. J Infect Dis 1999; 179 (1): 16-24.
    · extracted · source: references/10665-42458.sec-024.31.json
  43. O’Farrell N, Hoosen AA, Coetzee KD,Van den Ende J. Genital ulcer disease: accuracy of clinical diagnosis and strategies to improve control in Durban, South Africa. Genitourin Med 1994; 70 (1): 7-11.
    · extracted · source: references/10665-42458.sec-024.32.json
  44. O’Farrell N. Increasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI control programmes. Sex Transm Infect 1999; 75(6): 377-84.
    · extracted · source: references/10665-42458.sec-024.33.json
  45. Pannuti CS, Cristina M, Finck DS et al. Asymptomatic perianal shedding of herpes simplex virus in patients with acquired immunodeficiency syndrome. Arch Dermatol 1997; 133 (2): 180-3.
    · extracted · source: references/10665-42458.sec-024.34.json
  46. Patel R, Bodsworth NJ,Woolley P, et al.Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group. Genitourin Med 1997; 73 (2): 105-9.
    · extracted · source: references/10665-42458.sec-024.35.json
  47. Peacock JE; Kaplowitz LG, Sparling PF, et al. Intravenous aciclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial. Am J Med 1988; 85 (3): 301-6.
    · extracted · source: references/10665-42458.sec-024.36.json
  48. Ross JD, Smith IW, Elton RA.The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin Med 1993; 381-3.
    · extracted · source: references/10665-42458.sec-024.37.json
  49. Ryncarz AJ, Goddard J,Wald A, Huang ML, Roizman B, Corey L, et al. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J Clin Micro 1999; 1941-47 Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men.
    · extracted · source: references/10665-42458.sec-024.38.json
  50. Schacker T, Zeh J, Hu HL, Hill E, Corey L. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivation among human. J Infect Dis 1998; 178 (6): 1616-22.
    · extracted · source: references/10665-42458.sec-024.40.json
  51. Severson JL,Tyring SK. Relation between herpes simplex viruses and human immunodeficiency virus infections. Arch Dermatol 1999; 135 (11): 1393-7.
    · extracted · source: references/10665-42458.sec-024.41.json
  52. Smith JS, Herrero R, Munoz N, Eluf-Neto J, Ngelangel C, Bosch X,Ashley RL. Prevalence and risk factors for herpes simplex virus type 2 infection among middle-age women in Brazil and the Philippines. Sex Trans Dis 2001; 28 (4): 187-194.
    · extracted · source: references/10665-42458.sec-024.42.json
  53. Spruance SL,Tyring SK, DeGregorio B, Miller C, Beutner K.A large-scale, placebo-controlled, dose-ranging trial of peroral valciclovir for episodic treatment of recurrent herpes genitalis.Valciclovir HSV Study Group. Arch Intern Med 1996; 156 (15): 1729-35.
    · extracted · source: references/10665-42458.sec-024.43.json
  54. Sucato G,Wald A,Wakabayashi E,Vieira J, Corey L. Evidence of latencey and reactivation of both herpes simplex virus (HSV)-1 and HSV-2 in the genital region. J Infect Dis 1998; 177 (4): 1069-72.
    · extracted · source: references/10665-42458.sec-024.44.json
  55. Tyring SK, Douglas JM, Corey L, Spruance SL, Esmann J.A randomised, placebo-controlled comparison of oval valaciclovir and aciclovir in immunocompetent patients with recurrent genital herpes infections.The Valaciclovir International Study Group. Arch Dermatol 1998; 134 (2): 185-91.
    · extracted · source: references/10665-42458.sec-024.45.json
  56. Vontver LA, Reeves WC, Rattray M et al. Clinical course and diagnosis of genital herpes simplex virus infection and evaluation of topical surfactant therapy. Am J Obst Gyn 1979; 133 (5): 548-554.
    · extracted · source: references/10665-42458.sec-024.46.json
  57. Wagner HU,Van Dyck E, Roggen E, Nunn AJ, Kamali A, Schmid DS, Dobbins JG, Mulder DW. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. Int J STD AIDS. 1994; 5: 322-327.
    · extracted · source: references/10665-42458.sec-024.47.json
  58. Wald A, Langenberg AGM, Link K, Izu AE,Ashely R,Warren T,Tyring S, Douglas JM, Corey L. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 285: 3100-3106.
    · extracted · source: references/10665-42458.sec-024.48.json
  59. Wald A, Koutsky L,Ashley RL, Corey L. Genital herpes in a primary care clinic. Demographic and sexual correlates of herpes simplex type 2 infections. Sex Transm Dis 1997; 24 (3): 149-55.
    · extracted · source: references/10665-42458.sec-024.49.json
  60. Wald A, Link K. Meta-Analysis of the relationship between HIV and HSV-2. Unpublished. Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with aciclovir. Ann Intern Med 1996; 124 (1 Pt 1): 8-15.
    · extracted · source: references/10665-42458.sec-024.50.json
  61. Wald A, Zeh J, Selke S,Ashley RL, Corey L.Virologic characteristics of subclinical and symptomatic genital herpes. N Engl J Med 1995; 333 (12): 770-5.
    · extracted · source: references/10665-42458.sec-024.51.json
  62. Wald A. New therapies and prevention strategies for genital herpes. Clin Infect Dis 1999; 28 (Suppl 1): S4-13.
    · extracted · source: references/10665-42458.sec-024.52.json
  63. Weiss HA, Buvé A, Robinson NJ, et al. Study Group on Heterogeneity of HIV Epidemics in African Cities.The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 2001 15 (supp 4): S97-S108.
    · extracted · source: references/10665-42458.sec-024.53.json
  64. Whaley KJ, Barratt RA, Zeitlin L, Hoen TE, Cone RA. Nonoxynol-9 protects mice against vaginal transmission of genital herpes infections. J Infect Dis 1993; 168 (4): 1009-11.
    · extracted · source: references/10665-42458.sec-024.54.json
  65. Online: http://www.who.int/HIV_AIDS/http://www.who.int/Reproductive_health20 Avenue Appia , CH-1211 Geneva 27, Switzerland 20 Avenue Appia Internet: www.who.int/HIV_AIDS/20 Avenue Appia Telephone: +41 22 791 36 66 Fax: +41 22 791 41 87 E-mail: unaids@unaids.org Internet: www.unaids.org
    · extracted · link · source: references/10665-42458.sec-024.55.json